MFG
CNMD icon

Mendota Financial Group’s CONMED CNMD Stock Holding History

Mendota Financial Group’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$144 – 539
2024
Q3 		$144 Buy
+2
New +$141 ﹤0.01% 765

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Mendota Financial Group's CNMD Position: Q4 2024 in Review

Mendota Financial Group sold out of CONMED (CNMD) in Q4 2024, closing a stake of 2 shares — an estimated $144 sold.

Mendota Financial Group first reported a position in CNMD in Q3 2024 and held it in 1 quarter. The position peaked at $144 in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Mendota Financial Group reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Mendota Financial Group sold 2 CONMED shares in Q4 2024, an estimated $144.
  • Mendota Financial Group first reported a position in CONMED in Q3 2024 and held it in 1 quarter.
  • Mendota Financial Group's CONMED position peaked at $144 in Q3 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.